Skip to main content
Caplight Logo









Pax Neuroscience

Pax Neuroscience

Private
Rockville, MarylandHealthcare & Life Scienceshttps://www.paxneuroscience.com/

Last Round

Grant

Jan 1, 2022

Total Funding Raised

$1.57M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Pax Neuroscience is a biotechnology company that develops protein biomarker-based clinical laboratory services for the diagnosis and treatment of depression.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Mental Health, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

protein biomarkerclinical diagnosticsdepression diagnosisprecision psychiatrybiomarker testantidepressant responseblood-based testclinical trial supportcompanion diagnosticsbiotechdrug developmentproteomicslab servicesmental health tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pax Neuroscience Comparables

Compare Pax Neuroscience with similar companies based on industry and business-model similarity.

Pax Neuroscience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
MindX Sciences
81%
Circular Genomics
79%
Atlantic Diagnostic Laboratories
77%

Pax Neuroscience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 1, 2022
GrantSep 4, 2013

Key People

Founding team and executive leadership

Mark Rasenick

President, Chief Scientific Officer and Founder

Founding Team

Barry Frankel

Chief Executive Officer, Member Board of Directors

Executive Team

Robert Friesen

Chief Operating Officer, Member Board of Directors (ex officio)

Executive Team

Pax Neuroscience Investors

Notable investors and investment history

Pax Neuroscience investors
InvestorRounds
National Institute of Mental HealthGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 16, 2026

    Monthly visitors grew 135% MoM.

  • May 3, 2025

    Monthly visitors increased 114% MoM.

Pax Neuroscience Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Pax Neuroscience Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pax Neuroscience's valuation, stock price, and market status.

Firmographic Details

HeadquartersRockville, Maryland
Employee Range7
Year Founded2009
Last FundingJan 1, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?